Marc Engelhardt
Direttore Tecnico/Scientifico/R&S presso BASILEA PHARMACEUTICA AG
Provenienza dei contatti di primo grado di Marc Engelhardt
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 32 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Marc Engelhardt tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| AC IMMUNE SA | Pharmaceuticals: Major | Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| SYNGENTA | Chemicals: Agricultural | Director of Finance/CFO Corporate Secretary | |
| LINDT | Food: Specialty/Candy | Director/Board Member | |
| MEDIGENE AG | Biotechnology | Director/Board Member Director/Board Member | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Chairman Director/Board Member | |
| University of Freiburg | College/University | Undergraduate Degree Doctorate Degree | |
Marquard Media International AG
 Marquard Media International AG Publishing: Books/MagazinesConsumer Services Marquard Media International AG publishes magazines and periodicals. It also publishes a range of magazines from lifestyle, special interest, gaming, fitness and electronic entertainment. The company was founded by Jurg Marquard in 1965 and is headquartered in Baar, Switzerland. | Publishing: Books/Magazines | Director/Board Member | |
Elanco Tiergesundheit AG
 Elanco Tiergesundheit AG Pharmaceuticals: MajorHealth Technology Elanco Tiergesundheit AG manufactures animal vaccines. The firm provides pet health, livestock and Bioprotection products. The company's products include Atopica, Capstar, Deramaxx, Fortekor, Interceptor, Milbemax, Parc-tic and Sentinel. It is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer | |
Rinderknecht Klein & Stadelhofer
 Rinderknecht Klein & Stadelhofer Miscellaneous Commercial ServicesCommercial Services Rinderknecht Klein & Stadelhofer is a private company based in Zurich, Switzerland. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Varuma AG | Corporate Officer/Principal | ||
| Universität zu Köln | College/University | Doctorate Degree Undergraduate Degree | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Chairman | |
Roche Glycart AG
 Roche Glycart AG Pharmaceuticals: MajorHealth Technology Roche Glycart AG discovers and develops drugs. It is active in the research and development of new potent antibody-based products for the treatment of unmet clinical needs such as cancer. It uses its proprietary set of technologies to endow therapeutic antibodies. The company has developed glycoengineering technology (GlycoMAb) to boost a natural mechanism of action of therapeutic antibodies developed to mediate target cell killing. The company was founded in 2000 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
| University of Basel | College/University | Undergraduate Degree Graduate Degree Graduate Degree | |
| University of Zurich | College/University | Doctorate Degree | |
| IMPLENIA AG | Engineering & Construction | Director/Board Member | |
Speedel Pharma AG
 Speedel Pharma AG Pharmaceuticals: MajorHealth Technology Speedel Pharma AG develops drugs for the treatment of cardiovascular and metabolic diseases. It researches on Renin Inhibitors and also develops an Endothelin Receptor Anatagonist. The company also operates in the U.S. and Japan. It was founded in 1998 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
The Genetics Co., Inc.
 The Genetics Co., Inc. Medical/Nursing ServicesHealth Services The Genetics Company is a privately held drug discovery and development company active in the areas of cancer and neurodegenerative diseases. The company has identified small molecule inhibitors of two proprietary targets with in the Wnt-pathway, which is believed to play a crucial role in colon cancer. It has also identified small molecule inhibitors of BACE (beta-amyloid converting enzyme). In parallel, the company has identified and is in the process of further characterizing a series of novel growth-related drug target candidate genes for exploitation in cancer therapy. Headquartered in Zurich-Schlieren, Switzerland, the company currently has 29 employees. The Genetics Company offers you a range of high quality products to analyze Amyloid beta peptides x-40 and x-42 for basic research but also for pre-clinical and clinical development and in vitro diagnostics (IVD). Its CE-certified ELISA kits are the only clinically validated products for the determination of the Abeta42/40-Ratio in human CSF. These kits enable the early diagnosis of incipient Alzheimer's disease and can be used for patient stratification and monitoring in clinical trials of Alzheimer drug candidates. | Medical/Nursing Services | Director/Board Member | |
| HANSA BIOPHARMA AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
Anzamune Ltd.
 Anzamune Ltd. Pharmaceuticals: MajorHealth Technology Anzamune Ltd. develops therapeutic drugs. It also develops drugs for allergic disorders. Its products are based on chitin, a natural product found widely in shellfish and insect shells. The company was founded on June 6, 2007 and is headquartered in Ashhurst, New Zealand. | Pharmaceuticals: Major | Director/Board Member | |
| NOVIMMUNE SA | Medical/Nursing Services | Director/Board Member | |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Compliance Officer | |
APR Applied Pharma Research SA
 APR Applied Pharma Research SA BiotechnologyHealth Technology APR Applied Pharma Research SA develops and licenses healthcare products and technologies. It specializes in the development of oral and topical formulations in various healthcare regulatory areas ranging from Rx and OTC pharmaceuticals, nutraceuticals, dermocosmetics, and medical devices. The company was founded in 1990 and is headquartered in Balerna, Switzerland. | Biotechnology | Chairman | |
| Zurich Bar Association | Corporate Officer/Principal | ||
Basel Chamber of Commerce
 Basel Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services The Basel Chamber of Commerce is an organization that advocates for the interests of the industry and promotes the region as the most important logistics hub in Switzerland. The non-profit company is based in Basel, Switzerland. The company also has a Swiss School for International Business. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Mahissa | Chief Executive Officer | ||
| Canyon Pharmaceuticals AG | Chairman | ||
Badertscher Rechtsanwälte AG
 Badertscher Rechtsanwälte AG Miscellaneous Commercial ServicesCommercial Services Badertscher Rechtsanwälte AG is a national and internationally recognized law firm specializing in business, tax, and notary law, with offices in Zurich and Zug, Switzerland. The firm provides legal services to Swiss and foreign companies, public institutions, and individuals. The team of two dozen lawyers offers comprehensive legal advice in private and public law. The firm's approach is holistic, efficient, and solution-oriented, with a focus on tailored solutions that meet clients' needs. The firm's areas of expertise include insurance and liability law, corporate law, and public law. The firm also offers career opportunities for lawyers interested in joining their team. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Vectura Group Services Ltd.
 Vectura Group Services Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Philip Morris International, Inc., Vectura Group Services Ltd. provides business support services. The company is based in London, UK. | Miscellaneous Commercial Services | Director/Board Member | |
Turtle Capital Investment Ltd.
 Turtle Capital Investment Ltd. Financial ConglomeratesFinance Turtle Capital Investment Ltd. provides investment services. | Financial Conglomerates | Director/Board Member | |
Basilea Pharmaceutica China Ltd.
 Basilea Pharmaceutica China Ltd. Pharmaceuticals: MajorHealth Technology Part of Basilea Pharmaceutica AG, Basilea Pharmaceutica China Ltd. engages in research, development, and commercialization of anti-infective and anti-cancer drugs. The company is based in Nantong, China. The Chinese company was founded in 2002. The CEO is You Zhou. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| BIOSERGEN AB | Biotechnology | Director/Board Member | |
| First Salt AG | Chairman | ||
NEST AS
 NEST AS HomebuildingConsumer Durables Nest AS is an online store based in Oslo, Norway that was founded in 2018. The Norwegian company offers a wide range of trendy fashion, interior, and accessories for women. Nest AS takes pride in providing well-known quality brands such as Part Two, Ella & Iil, Reunion, and Is of Norway, among others. The company's online store is one of the largest in Norway, and customers can shop for their favorite items with ease. | Homebuilding | Director/Board Member | |
| Veritas Trust AG | Director/Board Member | ||
| Fundmaster AG | Director/Board Member | ||
| Munich Partners Invest AG | Chairman | ||
| Munich Partners AG | Chairman | ||
| First 4G AG | Chairman | ||
| First ELF AG | Chairman | ||
| PlusFour AG | Chairman | ||
Kenta Biotech AG
 Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland. | Biotechnology | Director/Board Member | |
Vaximm AG
 Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Miscellaneous Commercial Services | Director/Board Member |
Statistiche
Distribuzione geografica
| Svizzera | 32 |
| Germania | 6 |
| Svezia | 4 |
| Regno Unito | 3 |
| Danimarca | 3 |
Settori
| Health Technology | 21 |
| Commercial Services | 7 |
| Consumer Services | 6 |
| Health Services | 3 |
| Process Industries | 2 |
Posizioni
| Director/Board Member | 98 |
| Corporate Officer/Principal | 59 |
| Chairman | 39 |
| Independent Dir/Board Member | 30 |
| Chief Executive Officer | 20 |
Contatti più connessi
| Insiders | |
|---|---|
| Thomas M. Rinderknecht | 34 |
| Alf Gunnar Martin Nicklasson | 31 |
| Thomas Werner | 25 |
| Leonard Kruimer | 22 |
| Domenico Scala | 20 |
| Nicole Onetto | 17 |
| Steven Skolsky | 17 |
| Achim Kaufhold | 14 |
| Hans-Beat Gürtler | 13 |
| Werner Henrich | 10 |
| Carole A. Sable | 9 |
| Joachim Blatter | 7 |
| Elizabeth Rozek | 7 |
| Adesh Kaul | 6 |
| Damian Heller | 6 |
- Borsa valori
- Insiders
- Marc Engelhardt
- Connessioni Società
